Hypnotic Use for Sleep Disturbances in Breast Cancer: A Systematic Review

References (44)

1. 1 The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration [DOI]
2. 2 Epidemiology of insomnia: what we know and what we still need to learn [DOI]
3. 3 The Role of Actigraphy in the Study of Sleep and Circadian Rhythms [DOI]
4. 4 Insomnia: Definition, Prevalence, Etiology, and Consequences [DOI]
5. 5 Prevalence of Depression in Patients With Cancer [DOI]
6. 6 Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits [DOI]
7. 7 Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients [DOI]
8. 8 The basic physiology and pathophysiology of melatonin [DOI]
9. 9 Insomnia in the Context of Cancer: A Review of a Neglected Problem [DOI]
10. 10 Sleep disturbance in cancer patients [DOI]
11. 11 Meta-analysis of benzodiazepine use in the treatment of insomnia.
12. 12 Prevalence, Demographics, and Psychological Associations of Sleep Disruption in Patients With Cancer: University of Rochester Cancer Center–Community Clinical Oncology Program [DOI]
13. 13 Improvement of sleep quality in elderly people by controlled-release melatonin [DOI]
14. 14 Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis [DOI]
15. 15 Benzodiazepines and Zolpidem for Chronic Insomnia [DOI]
16. 16 Prevalence, Clinical Characteristics, and Risk Factors for Insomnia in the Context of Breast Cancer [DOI]
17. 17 Natural Course of Insomnia Comorbid With Cancer: An 18-Month Longitudinal Study [DOI]
18. 18 Effects of Sleep and Sleep Deprivation on Interleukin-6, Growth Hormone, Cortisol, and Melatonin Levels in Humans1 [DOI]
19. 19 Sleep and Quality of Life in Breast Cancer Patients [DOI]
20. 20 Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime [DOI]
21. 21 Novel melatonin-based therapies: potential advances in the treatment of major depression [DOI]
22. 22 Placebo-controlled trial of agomelatine in the treatment of major depressive disorder [DOI]
23. 23 Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder [DOI]
24. 24 Paroxetine Is an Effective Treatment for Hot Flashes: Results From a Prospective Randomized Clinical Trial [DOI]
25. 25 Insomnia and its treatment in women with breast cancer [DOI]
26. 26 A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer [DOI]
27. 27 Behavioral therapy intervention trial to improve sleep quality and cancer‐related fatigue [DOI]
28. 28 Sleep Disturbances in Women With Metastatic Breast Cancer [DOI]
29. 29 Interactions Between Tamoxifen and Antidepressants via Cytochrome P450 2D6 [DOI]
30. 30 Prevalence and Predictors of Sleep Difficulty in a National Cohort of Women With Primary Breast Cancer Three to Four Months Postsurgery [DOI]
31. 31 Utilization of hypnotic medication in the context of cancer: predictors and frequency of use [DOI]
32. 32 Relationship between quality of life and mood in long-term survivors of breast cancer treated with mastectomy [DOI]
33. 33 A survey of psychotropic drug prescriptions in an oncology population [DOI]
34. 34 The relative importance of specific risk factors for insomnia in women treated for early‐stage breast cancer [DOI]
35. 35 Management of Hot Flashes in Patients Who Have Breast Cancer With Venlafaxine and Clonidine: A Randomized, Double-Blind, Placebo-Controlled Trial [DOI]
36. 36 Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10-year period [DOI]
37. 37 A Pilot Trial of Paroxetine for the Treatment of Hot Flashes and Associated Symptoms in Women with Breast Cancer [DOI]
38. 38 Disrupted Sleep the Night Before Breast Surgery Is Associated with Increased Postoperative Pain [DOI]
39. 39 Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes [DOI]
40. 40 Sleep aid use during and following breast cancer adjuvant chemotherapy [DOI]
41. 41 Psychotropic medication during endocrine treatment for breast cancer [DOI]
42. 42 Do antidepressants reduce the effectiveness of tamoxifen?† [DOI]
43. 43 Sleep Aid Prescribing Practices during Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer [DOI]
44. 44 Hypnotic efficacy and safety of triazolam administered during the postoperative period [DOI]

Cited by 0

No indexed citations yet.

Related research

• Reproductive Factors Associated with the Risk of Breast Cancer among Malaysian Women: A Multi-Centre Case-Control Study — shares topic coverage
• Factors Predicting the Utilization of Breast Cancer Screening Services among Women Working in a Private University in Ogun State, Nigeria — shares topic coverage
• Breast Cancer Screening Trend Year 2017 among South-Western Nigeria Female Residents — shares topic coverage
• Complementary Medicine Intervention in Breast Cancer Patients with Pain — shares topic coverage
• Breast Cancer Knowledge and Mammography Uptake among Women Aged 40 Years and Above in Calabar Municipality, Nigeria — shares topic coverage